Buy Protalix Biotherapeutics Stock | PLX Stock Price & Latest News | Public.com
PLX

Protalix Biotherapeutics

$0.00 (0.00%)Today
    View Protalix Biotherapeutics (PLX) stock trends here

    About PLX

    Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 a...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.05
    -0.09
    -0.14
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.02

    Actual EPS
    Q1 2021

    Stats

    Market Cap$182,27M
    Volume305,43k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.02
    1 Year Low$2.04
    Open$4.14
    High$4.21
    Low$3.82

    Buy any stock with any amount of money.

    Download the App
    Download the app